|
Terumo received the following reported information: following a peripheral procedure, the doctor attempted to use the angio-seal by placing the bypass tube through the valve after locating the artery.Three devices were attempted; however, they did not function properly.However, a fourth device was used successfully.No blood loss was reported.
|
|
This report is being submitted as follow up no.1 to update section h3, and to provide the complete investigation results.This reported event has been reassessed and deemed not reportable based upon the investigation of the actual sample.One (1) 6 french angio-seal device was returned for product evaluation.The returned sample included three locators, a hemostasis sheath, and the carrier tube.The device was visually inspected and found to have been in used condition with visible signs of blood.The carrier tube and sheath were returned separate.The components were attempted to be mated for functional testing.The sheath and carrier tube were able to be fully mated and set to forward lock and the anchor was able to be deployed from the sheath.No other damage or issues were noted.The angio-seal device was returned for evaluation.The sheath and carrier tube were able to be fully mated and set to forward lock position, deploying the anchor from the distal sheath tip.As a result, the complaint could not be confirmed for an assembly issue of the sheath and carrier tube.The exact root cause could not be determined.The device history record (dhr) review determined that the device was in a conforming state when released from terumo control.There is no indication that any manufacturing, design, or quality system issues may have led to this event.Currently, no action is recommended since this risk evaluation is within the predetermined limits in the hazard based risk table (hbrt).
|